nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprazinone—Gastrointestinal ulcer haemorrhage—Methotrexate—systemic scleroderma	0.045	0.045	CcSEcCtD
Eprazinone—Necrosis—Captopril—systemic scleroderma	0.0313	0.0313	CcSEcCtD
Eprazinone—Fluid overload—Mycophenolic acid—systemic scleroderma	0.0311	0.0311	CcSEcCtD
Eprazinone—Ulcer—Mometasone—systemic scleroderma	0.0296	0.0296	CcSEcCtD
Eprazinone—Fluid overload—Lisinopril—systemic scleroderma	0.028	0.028	CcSEcCtD
Eprazinone—Ulcer—Captopril—systemic scleroderma	0.026	0.026	CcSEcCtD
Eprazinone—Abscess—Leflunomide—systemic scleroderma	0.0256	0.0256	CcSEcCtD
Eprazinone—Fluid overload—Mycophenolate mofetil—systemic scleroderma	0.0245	0.0245	CcSEcCtD
Eprazinone—Abscess—Mycophenolic acid—systemic scleroderma	0.0244	0.0244	CcSEcCtD
Eprazinone—Hyperkalaemia—Captopril—systemic scleroderma	0.0241	0.0241	CcSEcCtD
Eprazinone—Ulcer—Leflunomide—systemic scleroderma	0.0214	0.0214	CcSEcCtD
Eprazinone—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0195	0.0195	CcSEcCtD
Eprazinone—Abscess—Mycophenolate mofetil—systemic scleroderma	0.0193	0.0193	CcSEcCtD
Eprazinone—Hyperkalaemia—Mycophenolic acid—systemic scleroderma	0.019	0.019	CcSEcCtD
Eprazinone—Hyponatraemia—Captopril—systemic scleroderma	0.0179	0.0179	CcSEcCtD
Eprazinone—Hyperkalaemia—Lisinopril—systemic scleroderma	0.0171	0.0171	CcSEcCtD
Eprazinone—Phlebitis—Mycophenolic acid—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Eprazinone—Hyperkalaemia—Mycophenolate mofetil—systemic scleroderma	0.015	0.015	CcSEcCtD
Eprazinone—Hyponatraemia—Mycophenolic acid—systemic scleroderma	0.0141	0.0141	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.014	0.014	CcSEcCtD
Eprazinone—Flatulence—Pentoxifylline—systemic scleroderma	0.014	0.014	CcSEcCtD
Eprazinone—Necrosis—Prednisone—systemic scleroderma	0.0132	0.0132	CcSEcCtD
Eprazinone—Abscess—Prednisone—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Eprazinone—Abdominal discomfort—Azathioprine—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Eprazinone—Phlebitis—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Eprazinone—Hyponatraemia—Lisinopril—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Eprazinone—Infection—Pentoxifylline—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Eprazinone—Hyponatraemia—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Eprazinone—Necrosis—Methotrexate—systemic scleroderma	0.011	0.011	CcSEcCtD
Eprazinone—Ulcer—Prednisone—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Eprazinone—Abscess—Methotrexate—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Eprazinone—Infection—Mometasone—systemic scleroderma	0.00991	0.00991	CcSEcCtD
Eprazinone—Extravasation—Methotrexate—systemic scleroderma	0.00989	0.00989	CcSEcCtD
Eprazinone—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00914	0.00914	CcSEcCtD
Eprazinone—Ulcer—Methotrexate—systemic scleroderma	0.00913	0.00913	CcSEcCtD
Eprazinone—Flatulence—Leflunomide—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Eprazinone—Flatulence—Mycophenolic acid—systemic scleroderma	0.00832	0.00832	CcSEcCtD
Eprazinone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00791	0.00791	CcSEcCtD
Eprazinone—Body temperature increased—Mometasone—systemic scleroderma	0.00789	0.00789	CcSEcCtD
Eprazinone—Infection—Azathioprine—systemic scleroderma	0.0076	0.0076	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.0075	0.0075	CcSEcCtD
Eprazinone—Flatulence—Lisinopril—systemic scleroderma	0.00749	0.00749	CcSEcCtD
Eprazinone—Vomiting—Pentoxifylline—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Eprazinone—Rash—Pentoxifylline—systemic scleroderma	0.00729	0.00729	CcSEcCtD
Eprazinone—Dermatitis—Pentoxifylline—systemic scleroderma	0.00728	0.00728	CcSEcCtD
Eprazinone—Infection—Leflunomide—systemic scleroderma	0.00717	0.00717	CcSEcCtD
Eprazinone—Body temperature increased—Captopril—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Eprazinone—Nausea—Pentoxifylline—systemic scleroderma	0.00687	0.00687	CcSEcCtD
Eprazinone—Infection—Mycophenolic acid—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Eprazinone—Diarrhoea—Mometasone—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Eprazinone—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Eprazinone—Vomiting—Mometasone—systemic scleroderma	0.00634	0.00634	CcSEcCtD
Eprazinone—Rash—Mometasone—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Eprazinone—Dermatitis—Mometasone—systemic scleroderma	0.00628	0.00628	CcSEcCtD
Eprazinone—Infection—Lisinopril—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Eprazinone—Body temperature increased—Azathioprine—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Eprazinone—Diarrhoea—Captopril—systemic scleroderma	0.006	0.006	CcSEcCtD
Eprazinone—Nausea—Mometasone—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Eprazinone—Body temperature increased—Leflunomide—systemic scleroderma	0.00571	0.00571	CcSEcCtD
Eprazinone—Vomiting—Captopril—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Eprazinone—Rash—Captopril—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Eprazinone—Dermatitis—Captopril—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Eprazinone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Eprazinone—Infection—Mycophenolate mofetil—systemic scleroderma	0.0054	0.0054	CcSEcCtD
Eprazinone—Diarrhoea—Azathioprine—systemic scleroderma	0.00523	0.00523	CcSEcCtD
Eprazinone—Nausea—Captopril—systemic scleroderma	0.0052	0.0052	CcSEcCtD
Eprazinone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00519	0.00519	CcSEcCtD
Eprazinone—Diarrhoea—Leflunomide—systemic scleroderma	0.00494	0.00494	CcSEcCtD
Eprazinone—Body temperature increased—Lisinopril—systemic scleroderma	0.00491	0.00491	CcSEcCtD
Eprazinone—Vomiting—Azathioprine—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Eprazinone—Rash—Azathioprine—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Eprazinone—Dermatitis—Azathioprine—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Eprazinone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Eprazinone—Vomiting—Leflunomide—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Eprazinone—Rash—Leflunomide—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Eprazinone—Dermatitis—Leflunomide—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Eprazinone—Nausea—Azathioprine—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Eprazinone—Vomiting—Mycophenolic acid—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Eprazinone—Rash—Mycophenolic acid—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Eprazinone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Eprazinone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0043	0.0043	CcSEcCtD
Eprazinone—Nausea—Leflunomide—systemic scleroderma	0.00429	0.00429	CcSEcCtD
Eprazinone—Diarrhoea—Lisinopril—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Eprazinone—Nausea—Mycophenolic acid—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Eprazinone—Vomiting—Lisinopril—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Eprazinone—Rash—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Eprazinone—Dermatitis—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Eprazinone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Eprazinone—Nausea—Lisinopril—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Eprazinone—Infection—Prednisone—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Eprazinone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Eprazinone—Rash—Mycophenolate mofetil—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Eprazinone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Eprazinone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Eprazinone—Infection—Methotrexate—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Eprazinone—Body temperature increased—Prednisone—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Eprazinone—Diarrhoea—Prednisone—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Eprazinone—Body temperature increased—Methotrexate—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Eprazinone—Vomiting—Prednisone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Eprazinone—Rash—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Eprazinone—Dermatitis—Prednisone—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Eprazinone—Nausea—Prednisone—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Eprazinone—Diarrhoea—Methotrexate—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Eprazinone—Vomiting—Methotrexate—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Eprazinone—Rash—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Eprazinone—Dermatitis—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Eprazinone—Nausea—Methotrexate—systemic scleroderma	0.00183	0.00183	CcSEcCtD
